NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

CLARITY PHARMACEUTICALS LTD (AU: CU6)

 
CU6 Technical Analysis
4
As on 22nd Dec 2025 CU6 STOCK Price closed @ 3.16 and we RECOMMEND Sell for LONG-TERM with Stoploss of 3.40 & Strong Sell for SHORT-TERM with Stoploss of 4.31 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CU6STOCK Price

Open 3.60 Change Price %
High 3.72 1 Day -0.18 -5.39
Low 3.15 1 Week -0.05 -1.56
Close 3.16 1 Month -1.46 -31.60
Volume 5182911 1 Year -3.20 -50.31
52 Week High 6.41 | 52 Week Low 1.46
 
AU Australia Most Active Stocks
AGE 0.02 0.00%
EQR 0.08 0.00%
LOT 0.18 -5.26%
LKE 0.10 11.11%
SVL 0.23 15.00%
MEI 0.18 28.57%
VRC 0.01 %
CXO 0.27 8.00%
MKR 0.08 14.29%
PLS 4.01 2.04%
 
AU Australia Top Gainers Stocks
APV 0.02 100.00%
BKT 0.02 100.00%
BKT 0.02 100.00%
GLA 0.02 100.00%
MHC 0.03 50.00%
MHC 0.03 50.00%
MHC 0.03 50.00%
MHC 0.03 50.00%
MHC 0.03 50.00%
AU1 0.03 50.00%
 
AU Australia Top Losers Stocks
NTI 0.01 -50.00%
HIO 0.02 -33.33%
RCP 0.02 -33.33%
RCP 0.02 -33.33%
IRD 0.02 -33.33%
IRD 0.02 -33.33%
TGH 0.02 -33.33%
TGH 0.02 -33.33%
TGH 0.02 -33.33%
TGH 0.02 -33.33%
 
 
CU6
Daily Charts
CU6
Intraday Charts
Whats New @
Bazaartrend
CU6
Free Analysis
 
CU6 Important Levels Intraday
RESISTANCE4.26
RESISTANCE3.91
RESISTANCE3.69
RESISTANCE3.47
SUPPORT2.85
SUPPORT2.63
SUPPORT2.41
SUPPORT2.06
 
CU6 Forecast December 2025
4th UP Forecast5.65
3rd UP Forecast4.85
2nd UP Forecast4.36
1st UP Forecast3.86
1st DOWN Forecast2.46
2nd DOWN Forecast1.96
3rd DOWN Forecast1.47
4th DOWN Forecast0.67
 
CU6 Weekly Forecast
4th UP Forecast5.40
3rd UP Forecast4.68
2nd UP Forecast4.24
1st UP Forecast3.79
1st DOWN Forecast2.53
2nd DOWN Forecast2.08
3rd DOWN Forecast1.64
4th DOWN Forecast0.92
 
CU6 Forecast2025
4th UP Forecast12.81
3rd UP Forecast9.72
2nd UP Forecast7.8
1st UP Forecast5.89
1st DOWN Forecast0.43
2nd DOWN Forecast-1.48
3rd DOWN Forecast-3.4
4th DOWN Forecast-6.49
 
 
CU6 Other Details
Segment EQ
Market Capital 285588288.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CU6 Address
CU6
 
CU6 Latest News
 
Your Comments and Response on CLARITY PHARMACEUTICALS LTD
 
CU6 Business Profile
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, develops theranostic therapy and imaging products for the treatment of cancer in children and adults. Its lead product is SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2. The company is also developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; and SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. The company was incorporated in 2010 and is headquartered in Sydney, Australia. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service